KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Operating Expenses (2016 - 2025)

Cme (CME) has disclosed Operating Expenses for 17 consecutive years, with $629.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 8.8% to $629.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 4.21% increase, with the full-year FY2025 number at $2.3 billion, up 4.21% from a year prior.
  • Operating Expenses was $629.1 million for Q4 2025 at Cme, up from $565.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $629.1 million in Q4 2025 to a low of $487.5 million in Q1 2022.
  • A 5-year average of $534.0 million and a median of $528.2 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: dropped 11.64% in 2021, then rose 8.8% in 2025.
  • Cme's Operating Expenses stood at $515.6 million in 2021, then grew by 4.64% to $539.5 million in 2022, then increased by 6.78% to $576.1 million in 2023, then grew by 0.36% to $578.2 million in 2024, then rose by 8.8% to $629.1 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Operating Expenses are $629.1 million (Q4 2025), $565.0 million (Q3 2025), and $562.7 million (Q2 2025).